ANGO vs EW
AngioDynamics Inc (ANGO) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ANGO currently screens at market cap $378.5M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ANGO and EW stock pages for the full models.
Not investment advice.